The synthesis and biochemical pharmacology of enantiomerically pure methylated oxotremorine derivatives

Journal of Medicinal Chemistry
1993.0

Abstract

Previous pharmacological studies of methylated oxotremorine derivatives bearing substituents at the 3-, 4-, and 5-positions of the pyrrolidinone ring have been conducted using racemic mixtures, and not with optically active compounds. The synthesis and radioligand binding data of optically active, methylated oxotremorine derivatives at the 3- and 4-positions are described. There are significant pharmacological differences between the 3- and 4-position derivatives. The 4-position enantiomers have weak, approximately equal affinity and antagonist-like profiles, whereas the 3-position enantiomers have significantly different affinities and partial agonist-like profiles.

Knowledge Graph

Similar Paper

The synthesis and biochemical pharmacology of enantiomerically pure methylated oxotremorine derivatives
Journal of Medicinal Chemistry 1993.0
The synthesis and structure activity relationships of enantiomerically pure hydroxylated oxotremorine derivatives
Bioorganic & Medicinal Chemistry Letters 1992.0
Stereoselectivity of muscarinic receptors in vivo and in vitro for oxotremorine analogs. N-[4-tert-amino-2-butynyl]-5-methyl-2-pyrrolidones
Journal of Medicinal Chemistry 1985.0
Synthesis and in vitro characterization of novel amino terminally modified oxotremorine derivatives for brain muscarinic receptors
Journal of Medicinal Chemistry 1992.0
.beta.-Lactam analogs of oxotremorine. 3- and 4-Methyl-substituted 2-azetidinones
Journal of Medicinal Chemistry 1990.0
Synthesis and biological activity of enantiomers of a conformationally restricted muscarone analog
Bioorganic & Medicinal Chemistry Letters 1995.0
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide
Bioorganic & Medicinal Chemistry Letters 2008.0
Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogs of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5)
Journal of Medicinal Chemistry 1990.0
N-Substituent modulation of opiate agonist/antagonist activity in resolved 3-methyl-3-(m-hydroxyphenyl)piperidines
Journal of Medicinal Chemistry 1986.0
Bioisosteres of Arecoline: 1,2,3,6-Tetrahydro-5-pyridyl-Substituted and 3-Piperidyl-Substituted Derivatives of Tetrazoles and 1,2,3-Triazoles. Synthesis and Muscarinic Activity
Journal of Medicinal Chemistry 1994.0